ATE155795T1 - Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier - Google Patents

Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier

Info

Publication number
ATE155795T1
ATE155795T1 AT91909492T AT91909492T ATE155795T1 AT E155795 T1 ATE155795 T1 AT E155795T1 AT 91909492 T AT91909492 T AT 91909492T AT 91909492 T AT91909492 T AT 91909492T AT E155795 T1 ATE155795 T1 AT E155795T1
Authority
AT
Austria
Prior art keywords
leukoregulin
treatment
animal
animal infected
envelope virus
Prior art date
Application number
AT91909492T
Other languages
English (en)
Inventor
John J Hooks
Charles H Evans
Barbara Detrick
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE155795T1 publication Critical patent/ATE155795T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91909492T 1990-05-11 1991-05-10 Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier ATE155795T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/521,706 US5368853A (en) 1990-05-11 1990-05-11 Leukoregulin anti-viral therapy

Publications (1)

Publication Number Publication Date
ATE155795T1 true ATE155795T1 (de) 1997-08-15

Family

ID=24077805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909492T ATE155795T1 (de) 1990-05-11 1991-05-10 Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier

Country Status (11)

Country Link
US (2) US5368853A (de)
EP (1) EP0531341B1 (de)
JP (1) JPH0768136B2 (de)
AT (1) ATE155795T1 (de)
AU (1) AU644661B2 (de)
CA (1) CA2082270C (de)
DE (1) DE69126977T2 (de)
DK (1) DK0531341T3 (de)
ES (1) ES2103811T3 (de)
GR (1) GR3024236T3 (de)
WO (1) WO1991018014A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy
CA2420944A1 (en) 2000-08-30 2002-03-07 Chemocentryx, Inc. Inhibition of cmv infection and dissemination
CA2437201C (en) 2001-02-02 2008-11-18 Chemocentryx, Inc. Methods and compositions useful for stimulating an immune response
US7172085B2 (en) * 2001-12-04 2007-02-06 Beaudette Susan A Squeezable, fillable feeding device
US11246905B2 (en) 2016-08-15 2022-02-15 President And Fellows Of Harvard College Treating infections using IdsD from Proteus mirabilis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4849506A (en) * 1984-04-13 1989-07-18 Akzo N.V. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
US5082657A (en) * 1984-04-13 1992-01-21 Akzo N.V. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
EP0230574A3 (de) * 1986-01-31 1989-03-22 Yale University Pharmazeutische Zusammensetzungen gegen durch LAV/HTLV-III-Virus verursachte Infektionen und ihre Verwendung
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy

Also Published As

Publication number Publication date
US5368853A (en) 1994-11-29
DK0531341T3 (da) 1997-09-22
CA2082270A1 (en) 1991-11-12
US5529771A (en) 1996-06-25
GR3024236T3 (en) 1997-10-31
JPH05508834A (ja) 1993-12-09
DE69126977D1 (de) 1997-08-28
EP0531341B1 (de) 1997-07-23
CA2082270C (en) 1996-12-10
WO1991018014A1 (en) 1991-11-28
AU7873391A (en) 1991-12-10
ES2103811T3 (es) 1997-10-01
JPH0768136B2 (ja) 1995-07-26
EP0531341A4 (en) 1993-07-28
DE69126977T2 (de) 1997-11-27
AU644661B2 (en) 1993-12-16
EP0531341A1 (de) 1993-03-17

Similar Documents

Publication Publication Date Title
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
ES541103A0 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
EA199700215A1 (ru) Защита от вирусных инфекций путем колонизации слизистых оболочек генетически модифицированными бактериями
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
ATE175873T1 (de) Weitere indolderivate mit antiviraler wirkung
EP0616535A4 (de) Methode zur behandlung von varalen infektionen.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DE3751772D1 (de) Impfstoff zur behandlung von hsv
ATE155795T1 (de) Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ES2036526T3 (es) Composiciones de interferon.
BR9306207A (pt) Composiçao farmacéutica e processo para o tratamento de infecçao ou doença causada pelo vírus da hepatite b processo para a preparaçao da composiçao e uso de fiau ou de uma pró-droga ou metabolito do mesmo
DE3765137D1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von virus-infektionen.
DK0653939T3 (da) Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
FI872363A7 (fi) Bakteriosiinit ja niitä sisältävät koostumukset virusinfektioiden detektioon ja hoitoon.
DE69006187D1 (de) Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren.
ATE196424T1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
DE59003111D1 (de) Arzneimittel und ihre Verwendung zur Behandlung von Parasitosen.
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee